Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000
Abstract
Citation for published version (Harvard): Ness, AR, Waylen, A, Hurley, K, Jeffreys, M, Penfold, C, Pring, M, Leary, SD, Allmark, C, Toms, S, Ring, S, Peters, TJ, Hollingworth, W, Worthington, H, Nutting, C, Fisher, S, Rogers, SN, Thomas, SJ, Mehanna, H & 5000 Study Team, HAN 2016, 'Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000', Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, vol. 41, no. 6, pp. 804-809. https://doi.org/10.1111/coa.12548
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 5,511 participants or records.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.